Modulation of autophagy for the treatment of liver diseases

Expert Opinion on Investigational Drugs

Volumn 23, Issue 7, 2014, Pages 965-977

  Gracia Sancho, Jordi ^a   Guixé Muntet, Sergi ^a   Hide, Diana ^a   Bosch, Jaime ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Chloroquine; Cirrhosis; Hepatic; Ischemia; Non alcoholic fatty liver disease

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 3 METHYLADENINE; BAFILOMYCIN A1; BORTEZOMIB; CARBAMAZEPINE; CHLOROQUINE; CISPLATIN; DACTOLISIB; EVEROLIMUS; FERROQUINE; HYDROXYCHLOROQUINE; LIPID; NILOTINIB; OXALIPLATIN; RAPAMYCIN; SORAFENIB; VORINOSTAT;

APOPTOSIS; AUTOPHAGY; CELL METABOLISM; CELL PROLIFERATION; DRUG TARGETING; FATTY LIVER; HEPATITIS B; HEPATITIS C; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; ISCHEMIC PRECONDITIONING; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LIVER ISCHEMIA; NONALCOHOLIC FATTY LIVER; NONHUMAN; REPERFUSION INJURY; REVIEW; VIRUS HEPATITIS; ANIMAL; LIVER DISEASES;

ANIMALS; AUTOPHAGY; HUMANS; LIVER DISEASES; REPERFUSION INJURY;

EID: 84902340150     PISSN: 13543784     EISSN: 17447658     Source Type: Journal    
DOI: 10.1517/13543784.2014.912274     Document Type: Review

References (96)

1. Tanida I. Autophagosome formation and molecular mechanism of autophagy. Antioxid Redox Signal 2011;14:2201-14
2. Avruch J, Long X, Ortiz-Vega S, et al. Amino acid regulation of TOR complex 1. Am J Physiol Endocrinol Metab 2009;296:E592-602
3. Egan DF, Shackelford DB, Mihaylova MM, et al. Phosphorylation of ULK1 (hATG1) by AMP-Activated protein kinase connects energy sensing to mitophagy. Science 2011;331:456-61
4. Kim J, Kim YC, Fang C, et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 2013;152:290-303
5. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010;140:313-26
6. Michelotti GA, Machado MV, Diehl AM. NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol 2013;10:656-65
7. Singh R, Kaushik S, Wang Y, et al. Autophagy regulates lipid metabolism. Nature 2009;458:1131-5
8. Koga H, Kaushik S, Cuervo AM. Altered lipid content inhibits autophagic vesicular fusion. FASEB J 2010;24:3052-65
9. Papackova Z, Dankova H, Palenickova E, et al. Effect of short- And long-term high-fat feeding on autophagy flux and lysosomal activity in rat liver. Physiol Res 2012;61(Suppl 2):S67-76
10. Scott PH, Brunn GJ, Kohn AD, et al. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc Natl Acad Sci USA 1998;95:7772-7 (Pubitemid 28293329
11. Sarbassov DD, Ali SM, Sabatini DM. Growing roles for the mTOR pathway. Curr Opin Cell Biol 2005;17:596-603 (Pubitemid 41540408
12. Neufeld TP. TOR-dependent control of autophagy: Biting the hand that feeds. Curr Opin Cell Biol 2010;22:157-68
13. Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006;7:606-19 (Pubitemid 44100518
14. Liu HY, Han J, Cao SY, et al. Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: Inhibition of FoxO1- dependent expression of key autophagy genes by insulin. J Biol Chem 2009;284:31484-92
15. Korsheninnikova E, van der Zon GC, Voshol PJ, et al. Sustained activation of the mammalian target of rapamycin nutrient sensing pathway is associated with hepatic insulin resistance, but not with steatosis, in mice. Diabetologia 2006;49:3049-57 (Pubitemid 44730309
16. Naito T, Kuma A, Mizushima N. Differential contribution of insulin and amino acids to the mTORC1-Autophagy pathway in the liver and muscle. J Biol Chem 2013;288:21074-81
17. Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 2011;13:1016-23
18. Nagata D, Hirata Y. The role of AMPactivated protein kinase in the cardiovascular system. Hypertens Res 2010;33:22-8
19. Klionsky DJ, Codogno P, Cuervo AM, et al. A comprehensive glossary of autophagy-related molecules and processes. Autophagy 2010;6:438-48
20. Cui M, Yu H, Wang J, et al. Chronic caloric restriction and exercise improve metabolic conditions of dietary-induced obese mice in autophagy correlated manner without involving AMPK. J Diabetes Res 2013;2013:852754
21. Yang L, Li P, Fu S, et al. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab 2010;11:467-78
22. Ogata M, Hino S, Saito A, et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 2006;26:9220-31 (Pubitemid 44904418
23. Zhou L, Zhang J, Fang Q, et al. Autophagy-mediated insulin receptor down-regulation contributes to endoplasmic reticulum stress-induced insulin resistance. Mol Pharmacol 2009;76:596-603
24. Ganley IG, Wong PM, Gammoh N, et al. Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest. Mol Cell 2011;42:731-43
25. Lin CW, Zhang H, Li M, et al. Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-Alcoholic fatty liver conditions in mice. J Hepatol 2013;58:993-9
26. Yamaguchi K, Yang L, McCall S, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 2007;45:1366-74 (Pubitemid 46918320
27. Amir M, Czaja MJ. Autophagy in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol 2011;5:159-66
28. Han X, Turdi S, Hu N, et al. Influence of long-term caloric restriction on myocardial and cardiomyocyte contractile function and autophagy in mice. J Nutr Biochem 2012;23:1592-9
29. Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol 2013;13:722-37
30. Ait-Goughoulte M, Kanda T, Meyer K, et al. Hepatitis C virus genotype 1a growth and induction of autophagy. J Virol 2008;82:2241-9 (Pubitemid 351293524
31. Sir D, Chen WL, Choi J, et al. Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response. Hepatology 2008;48:1054-61
32. Shinohara Y, Imajo K, Yoneda M, et al. Unfolded protein response pathways regulate Hepatitis C virus replication via modulation of autophagy. Biochem Biophys Res Commun 2013;432:326-32
33. Dreux M, Gastaminza P, Wieland SF, et al. The autophagy machinery is required to initiate hepatitis C virus replication. Proc Natl Acad Sci USA 2009;106:14046-51
34. Mohl BP, Tedbury PR, Griffin S, et al. Hepatitis C virus-induced autophagy is independent of the unfolded protein response. J Virol 2012;86:10724-32
35. Mizui T, Yamashina S, Tanida I, et al. Inhibition of hepatitis C virus replication by chloroquine targeting virus-Associated autophagy. J Gastroenterol 2010;45:195-203
36. Chandra PK, Bao L, Song K, et al. HCV infection selectively impairs type I but not type III IFN signaling. Am J Pathol 2014;184:214-29
37. Sir D, Tian Y, Chen WL, et al. The early autophagic pathway is activated by hepatitis B virus and required for viral DNA replication. Proc Natl Acad Sci USA 2010;107:4383-8
38. Tang H, Da L, Mao Y, et al. Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via upregulation of beclin 1 expression. Hepatology 2009;49:60-71
39. Vausselin T, Calland N, Belouzard S, et al. The antimalarial ferroquine is an inhibitor of hepatitis C virus. Hepatology 2013;58:86-97
40. Thoen LF, Guimaraes EL, Dolle L, et al. A role for autophagy during hepatic stellate cell activation. J Hepatol 2011;55:1353-60
41. Hernández-Gea V, Ghiassi-Nejad Z, Rozenfeld R, et al. Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 2012;142:938-46
42. Hidvegi T, Ewing M, Hale P, et al. An autophagy-enhancing drug promotes degradation of mutant alpha1-Antitrypsin Z and reduces hepatic fibrosis. Science 2010;329:229-32
43. Puls F, Goldschmidt I, Bantel H, et al. Autophagy-enhancing drug carbamazepine diminishes hepatocellular death in fibrinogen storage disease. J Hepatol 2013;59:626-30
44. Sasaki M, Miyakoshi M, Sato Y, et al. Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis. Lab Invest 2010;90:835-43
45. Sasaki M, Miyakoshi M, Sato Y, et al. A possible involvement of p62/ sequestosome-1 in the process of biliary epithelial autophagy and senescence in primary biliary cirrhosis. Liver Int 2012;32:487-99
46. Sasaki M, Miyakoshi M, Sato Y, et al. Increased expression of mitochondrial proteins associated with autophagy in biliary epithelial lesions in primary biliary cirrhosis. Liver Int 2013;33:312-20
47. Takamura A, Komatsu M, Hara T, et al. Autophagy-deficient mice develop multiple liver tumors. Genes Dev 2011;25:795-800
48. Inami Y, Waguri S, Sakamoto A, et al. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J Cell Biol 2011;193:275-84
49. Song J, Qu Z, Guo X, et al. Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells. Autophagy 2009;5:1131-44
50. Shimizu S, Takehara T, Hikita H, et al. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma. Int J Cancer 2012;131:548-57
51. Hui B, Shi YH, Ding ZB, et al. Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma. Cancer 2012;118:5560-71
52. Yu HC, Hou DR, Liu CY, et al. Cancerous inhibitor of protein phosphatase 2A mediates bortezomibinduced autophagy in hepatocellular carcinoma independent of proteasome. PLoS One 2013;8:e55705
53. Xu N, Zhang J, Shen C, et al. Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell. Biochem Biophys Res Commun 2012;423:826-31
54. Ding ZB, Hui B, Shi YH, et al. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation. Clin Cancer Res 2011;17:6229-38
55. Lazova R, Camp RL, Klump V, et al. Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin Cancer Res 2012;18:370-9
56. Toshima T, Shirabe K, Matsumoto Y, et al. Autophagy enhances hepatocellular carcinoma progression by activation of mitochondrial beta-oxidation. J Gastroenterol 2013;doi:10.1007/s00535-013-0835-9
57. Yu HC, Lin CS, Tai WT, et al. Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation. J Biol Chem 2013;288:18249-59
58. Vara D, Salazar M, Olea-Herrero N, et al. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: Role of AMPK-dependent activation of autophagy. Cell Death Differ 2011;18:1099-111
59. Liu YL, Yang PM, Shun CT, et al. Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. Autophagy 2010;6:1057-65
60. Li J, Yang B, Zhou Q, et al. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelialmesenchymal transition. Carcinogenesis 2013;34:1343-51
61. Peng YF, Shi YH, Shen YH, et al. Promoting colonization in metastatic HCC cells by modulation of autophagy. PLoS One 2013;8:e74407
62. Lemasters JJ, Thurman RG. Reperfusion injury after liver preservation for transplantation. Annu Rev Pharmacol Toxicol 1997;37:327-38 (Pubitemid 27238879
63. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003;284:G15-26
64. Peralta C, Jimenez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: Effects on the liver sinusoidal milieu. J Hepatol 2013;59:1094-106
65. Minor T, Stegemann J, Hirner A, et al. Impaired autophagic clearance after cold preservation of fatty livers correlates with tissue necrosis upon reperfusion and is reversed by hypothermic reconditioning. Liver Transpl 2009;15:798-805
66. Gotoh K, Lu Z, Morita M, et al. Participation of autophagy in the initiation of graft dysfunction after rat liver transplantation. Autophagy 2009;5:351-60
67. Gracia-Sancho J, Garcia-Caldero H, Hide D, et al. Simvastatin maintains function and viability of steatotic rat livers procured for transplantation. J Hepatol 2013;58:1140-6
68. Kim JS, Nitta T, Mohuczy D, et al. Impaired autophagy: A mechanism of mitochondrial dysfunction in anoxic rat hepatocytes. Hepatology 2008;47:1725-36 (Pubitemid 351702754
69. Wang JH, Ahn IS, Fischer TD, et al. Autophagy suppresses age-dependent ischemia and reperfusion injury in livers of mice. Gastroenterology 2011;141:2188-99
70. Sun K, Xie X, Liu Y, et al. Autophagy lessens ischemic liver injury by reducing oxidative damage. Cell Biosci 2013;3:26-3
71. Domart MC, Esposti DD, Sebagh M, et al. Concurrent induction of necrosis, apoptosis, and autophagy in ischemic preconditioned human livers formerly treated by chemotherapy. J Hepatol 2009;51:881-9
72. Degli ED, Sebagh M, Pham P, et al. Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes. Cell Death Dis 2011;2:e111
73. Shin T, Kuboki S, Huber N, et al. Activation of peroxisome proliferatoractivated receptor-gamma during hepatic ischemia is age-dependent. J Surg Res 2008;147:200-5
74. Cardinal J, Pan P, Dhupar R, et al. Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/ reperfusion injury. Hepatology 2009;50:565-74
75. Liu A, Fang H, Dahmen U, et al. Chronic lithium treatment protects against liver ischemia/reperfusion injury in rats. Liver Transpl 2013;19:762-72
76. Weckman A, Di IA, Rotondo F, et al. Autophagy in the endocrine glands. J Mol Endocrinol 2014;52:R151-63
77. Sinha RA, Farah BL, Singh BK, et al. Caffeine stimulates hepatic lipid metabolism via autophagy-lysosomal pathway. Hepatology 2014;59(4):1366-80
78. Nepal S, Park PH. Activation of autophagy by globular adiponectin attenuates ethanol-induced apoptosis in HepG2 cells: Involvement of AMPK/ FoxO3A axis. Biochim Biophys Acta 2013;1833:2111-25
79. Ding WX, Li M, Chen X, et al. Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice. Gastroenterology 2010;139:1740-52
80. Wu D, Wang X, Zhou R, et al. Alcohol steatosis and cytotoxicity: The role of cytochrome P4502E1 and autophagy. Free Radic Biol Med 2012;53:1346-57
81. Li S, Li J, Shen C, et al. tert-Butylhydroquinone (tBHQ) protects hepatocytes against lipotoxicity via inducing autophagy independently of Nrf2 activation. Biochim Biophys Acta 2013;1841:22-33
82. Li L, Hai J, Li Z, et al. Resveratrol modulates autophagy and NF-kappaB activity in a murine model for treating non-Alcoholic fatty liver disease. Food Chem Toxicol 2014;63:166-73
83. Zeng T, Zhang CL, Song FY, et al. PI3K/Akt pathway activation was involved in acute ethanol-induced fatty liver in mice. Toxicology 2012;296:56-66
84. Su WC, Chao TC, Huang YL, et al. Rab5 and class III phosphoinositide 3- kinase Vps34 are involved in hepatitis C virus NS4B-induced autophagy. J Virol 2011;85:10561-71
85. Li J, Liu Y, Wang Z, et al. Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment. J Virol 2011;85:6319-33
86. Shaker ME, Ghani A, Shiha GE, et al. Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases. Biochim Biophys Acta 2013;1833:1992-2003
87. Thomas HE, Mercer CA, Carnevalli LS, et al. mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma. Sci Transl Med 2012;4:139ra84
88. Longo L, Platini F, Scardino A, et al. Autophagy inhibition enhances anthocyanin-induced apoptosis in hepatocellular carcinoma. Mol Cancer Ther 2008;7:2476-85
89. Feng R, Wang SY, Shi YH, et al. Delphinidin induces necrosis in hepatocellular carcinoma cells in the presence of 3-methyladenine, an autophagy inhibitor. J Agric Food Chem 2010;58:3957-64
90. Guo XL, Li D, Hu F, et al. Targeting autophagy potentiates chemotherapyinduced apoptosis and proliferation inhibition in hepatocarcinoma cells. Cancer Lett 2012;320:171-9
91. Wang Y, Han C, Lu L, et al. Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells. Hepatology 2013;58:995-1010
92. Ko H, Kim YJ, Park JS, et al. Autophagy inhibition enhances apoptosis induced by ginsenoside Rk1 in hepatocellular carcinoma cells. Biosci Biotechnol Biochem 2009;73:2183-9
93. Shi YH, Ding ZB, Zhou J, et al. Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy 2011;7:1159-72
94. Zaouali MA, Boncompagni E, Reiter RJ, et al. AMPK involvement in endoplasmic reticulum stress and autophagy modulation after fatty liver graft preservation: A role for melatonin and trimetazidine cocktail. J Pineal Res 2013;55(1):65-78
95. Wang D, Ma Y, Li Z, et al. The role of AKT1 and autophagy in the protective effect of hydrogen sulphide against hepatic ischemia/reperfusion injury in mice. Autophagy 2012;8:954-62
96. Fang H, Liu A, Dahmen U, et al. Dual role of chloroquine in liver ischemia reperfusion injury: Reduction of liver damage in early phase, but aggravation in late phase. Cell Death Dis 2013;4:e694.